Avantax Planning Partners’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
O
TCM
CCA
Avantax Planning Partners's RGEN Position: Q2 2018 in Review
Avantax Planning Partners sold out of Repligen (RGEN) in Q2 2018, closing a stake of 243 shares — an estimated $9K sold.
Avantax Planning Partners first reported a position in RGEN in Q1 2018 and held it in 1 quarter. The position peaked at $9K in Q1 2018. 196 funds tracked by Wall St. Rank hold RGEN as of Q2 2018.
- Avantax Planning Partners reported no remaining Repligen position as of Q2 2018 after selling out during the quarter.
- Avantax Planning Partners sold 243 Repligen shares in Q2 2018, an estimated $9K.
- Avantax Planning Partners first reported a position in Repligen in Q1 2018 and held it in 1 quarter.
- Avantax Planning Partners's Repligen position peaked at $9K in Q1 2018.
- 196 funds tracked by Wall St. Rank held Repligen as of Q2 2018.
Based on Avantax Planning Partners's 13F filing for Q2 2018, filed 13 Aug 2018.